Sign in Subscribe
Featured

CF Benchmarks Recap - Issue 26

Crypto attention is already shifting to the next opportunity – a potential direct listing of Coinbase’s best-established rival, Kraken, in 2022

Ken Odeluga, CF Benchmarks

• 4 min read
CF Benchmarks Recap - Issue 26

  • SEC examines WisdomTree’s planned Bitcoin ETF

  • CME ETH open interest up 66%

  • Video: get a head start on CME Micro Bitcoin Futures

Screenshot-2021-04-09-at-22.53.58
Quiet and loud market launches
More remarkable than Coinbase’s planned direct listing next week that will make it the first major cryptocurrency exchange to go public whilst, in effect, placing the stock among the largest crypto-related equity assets to trade on traditional exchanges, is that it’s already old news - to the industry. The event is set to become a contender for the biggest U.S. stock flotation of the year, complete with a prospective valuation that’s just as contentious as any other FAANG-like IPO of recent years, but crypto attention is already shifting to the next such opportunity – a potential direct listing of Coinbase’s best-established rival, Kraken, in 2022. In quieter revolutions, news from the largest regulated cryptocurrency derivatives market, constituted by CME Group Bitcoin and Ether contracts, also underlines that the normalisation phase is well underway. In a refinement that puts CME’s BTC Futures on par with myriad well-worn instruments available at the venue, plans for the launch of Micro Bitcoin Futures in May are well advanced. Per diminutive tradable versions of contracts on markets like E-mini-S&P 500 Futures, Micro BTC (MBT) contracts will provide scope for tighter control of trade sizing given that they’ll be 1/50th the size of CME’s existing Bitcoin Futures. Like CME BTC, MBT will settle to the CME CF Bitcoin Reference Rate, the cast-iron regulation of which helps explain why the effective margin required to trade MBT will still be more demanding than that required to trade Bitcoin at unregulated venues. Meanwhile, the latest in what seemed like an interminable string of fresh Bitcoin record peaks has held for a third week. The all-time high of the only regulated continuous BTC benchmark, the CME CF Bitcoin Real Time Index, remains $61,750.98, timestamp 13/03/2021, 20:42:21.

SEC eyes WisdomTree Bitcoin ETF
One of the most closely watched candidates among the feverish round of Bitcoin ETF applications lodged with the SEC took a step closer to a decision on Friday. The Commission published a customary notice signalling that it would begin examining the proposal to offer WisdomTree Bitcoin Trust (BTCW) that arrived last month. BTCW is only the second of at least 8 proposed Bitcoin ETFs on the SEC’s desk so far this year that it’s known to be actively considering.

Grayscale looks to recalibrate GBTC
The provider of the largest existing crypto investment product has confirmed that it won’t stand aside from the push towards open-ended products. Grayscale is “100% committed” to converting its flagship Grayscale Bitcoin Trust into an ETF. It could also pursue ETF status for its other vehicles, like Grayscale Ethereum Trust, though has offered few details or a timeline, so far.

CME’s ETH open interest accelerates
CME Group’s Bitcoin and Ether Open Interest (OI) diverged in March, despite record price highs for both. CryptoCompare’s latest Exchange Review records OI in CME’s new ETH contract up 66% since launch to $102m. BTC OI slipped 15% to $2bn. Spot volumes at major exchanges saw a third straight monthly increase, up 5.9% to $2.5 trillion.

The Returns: CF PAX Gold-Dollar Settlement Price
Like it’s physical counterpart, the only fully regulated tokenised gold crypto has underperformed most digital assets as the risk aversion that traditionally favours ‘safe havens’ has been in short supply. Though PAXG has traded since August 2019, PAXGUSD_RR’s inception was a year later. It has since steadily gone against the grain of much of the asset class, leaving it with a small negative 8-month return by April.
Screenshot-2021-04-10-at-01.26.11

Featured benchmarks: CME CF Bitcoin Reference Rate

Video: ‘Learn about Micro Bitcoin futures’ – CME Group

The CME Group’s planned launch of Micro Bitcoin Futures (MBT) in May 2021 will be the latest product based on the CME Bitcoin Futures since the exchange’s flagship crypto contract began trading in 2017. Like existing BTC futures, MBT will also settle to the only regulated Bitcoin price, CME CF Bitcoin Reference Rate (BRR). At 1/50th the size of a full CME BTC contract, MBT will facilitate increased control and flexibility for risk management. Like all new financial tools though, MBT may demand a moderate learning curve for many participants. The official CME video linked below is an excellent introduction to the new contract’s specifications, features and potential applications, including a clear breakdown of the BRR and an explanation of why it is integral to CME Bitcoin contracts.

Catch the lesson by clicking here.

Screenshot-2021-04-10-at-02.25.35

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell any of the underlying instruments cited including but not limited to cryptoassets, financial instruments or any instruments that reference any index provided by CF Benchmarks Ltd. This communication is not intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. Please contact your financial adviser or professional before making an investment decision.

CF Benchmarks Ltd (“CF Benchmarks”), a company registered in England and Wales with company number 11654816 and authorised and regulated by the Financial Conduct Authority. Information about us can be found on the Financial Services Register (register number 847100).

Registered Office: 6th Floor One London Wall, London, United Kingdom, EC2Y 5EB.

You agree not to, and have no rights to, use the CF Benchmarks Data to create, calculate, issue, settle, maintain, support or develop any financial instruments (including but, without limitation exchange traded products, certificates, warrants, contracts for difference, swaps, binary options, structured products), indices, products, services (including but without limitation, portfolio management services, pre- and post-trade risk management services, or valuation services) or any other derivative works without the express written consent of CF Benchmarrks.

You agree not to analyze, reverse-engineer or disassemble any CF Benchmarks data and not to insert any code or product to manipulate the Website content in any way that affects any user’s experience. Unless CF Benchmarks gives you prior written permission, use of any Web browsers (other than generally available third-party browsers), engines, scripts, software, spiders, robots, avatars, agents, tools or other devices or mechanisms (such as crawlers, browser plug-ins and add-ons, or other technology) to navigate, access, copy in bulk, retrieve, harvest, index, search or analyse any portion of the Website is strictly prohibited.

No part of this information may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of CF Benchmarks Ltd. Use and distribution of the CF Benchmarks data requires a license from CF Benchmarks or its authorized licensing agents.

All information is provided for information purposes only. All information and data contained on this website is obtained by CF Benchmarks, from sources believed by it to be accurate and reliable. Such information and data is provided "as is" without warranty of any kind.

CF Benchmarks, nor its directors, officers, employees, partners or licensors make any claim, prediction, warranty or representation whatsoever, expressly or implied, either as to the accuracy, timeliness, completeness or merchantability of any information or of results to be obtained from the use of the CF Benchmarks indices or the fitness or suitability of the same indices for any particular purpose to which they might be put. Any representation of historical data accessible through CF Benchmarks indices is provided for information purposes only and is not a reliable indicator of future performance.

No responsibility or liability can be accepted by CF Benchmarks nor their respective directors, officers, employees, partners or licensors for any loss or damage in whole or in part caused by, resulting from, or relating to any error (negligent or otherwise) or other circumstance involved in procuring, collecting, compiling, interpreting, analysing, editing, transcribing, transmitting, communicating or delivering any such information or data or from use of this website or links to this website.

CF Benchmarks and its respective directors, officers, employees, partners or licensors do not provide investment advice and nothing accessible through CF Benchmarks, should be taken as constituting financial or investment advice or a financial promotion. Charts and graphs are provided for illustrative purposes only. Index returns shown may not represent the results of the actual trading of any assets.

CF Benchmarks is a member of the Crypto Facilities group of companies which is in turn a member of the Payward, Inc. group of companies. Payward, Inc. is the owner and operator of the Kraken Exchange, a venue that facilitates the trading of cryptocurrencies. The Kraken Exchange is a source of input data for certain CF Benchmarks indices. Payward, Inc. is the owner and operator of the Staked, a venue that operates the block production nodes for decentralized PoS protocols on behalf of institutional investors. Staked.us is a source of input data for certain CF Benchmarks indices.

Please refer to the individual product family documentation for more information about applicable input data sources.